Form 8-K - Current report:
SEC Accession No. 0001567892-25-000020
Filing Date
2025-05-06
Accepted
2025-05-06 06:45:20
Documents
15
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnk-20250506.htm   iXBRL 8-K 25715
2 EX-99.1 mnkexhibit991q12025.htm EX-99.1 365942
6 MNK LOGO mallinckrodtlogoa11.jpg GRAPHIC 18959
  Complete submission text file 0001567892-25-000020.txt   576223

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20250506.xsd EX-101.SCH 2164
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20250506_lab.xml EX-101.LAB 22462
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20250506_pre.xml EX-101.PRE 13154
17 EXTRACTED XBRL INSTANCE DOCUMENT mnk-20250506_htm.xml XML 2708
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 25915150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)